Isolation of a jadomycin incorporating L-ornithine, analysis of antimicrobial activity and jadomycin reactive oxygen species (ROS) generation in MDA-MB-231 breast cancer cells

Forget, Stephanie M and Robertson, Andrew W and Hall, Steven R and MacLeod, Jeanna M and Overy, David P and Kerr, Russell G and Goralski, Kerry B and Jakeman, David L (2018) Isolation of a jadomycin incorporating L-ornithine, analysis of antimicrobial activity and jadomycin reactive oxygen species (ROS) generation in MDA-MB-231 breast cancer cells. The Journal of antibiotics, 71 (8). pp. 722-730. ISSN 0021-8820

Full text not available from this repository.

Abstract

Herein, we report the characterization and antimicrobial activity of a previously unreported jadomycin (1) obtained from a culture of S. venezuelae ISP5230 with L-ornithine (Orn). 1 arises from the rearrangement of a putative five-membered ring containing jadomycin incorporating Orn, whereby intramolecular attack of the E-ring carbonyl from the δ-NH2 group of the Orn side chain results in collapse of the oxazolone ring and formation of a stable six-membered lactam. This rearrangement produces a jadomycin with a 3a hemiaminal position that is susceptible to solvolysis. A structure-activity relationship is discussed based on the antimicrobial activity of 1 compared to previously reported jadomycins, providing evidence that the presence of a 3a hemiaminal enhances activity against Gram-positive bacteria. Additionally, assays to quantify reactive oxygen species (ROS) generation and cell viability were performed using a series of nine jadomycins. Compound 1 was found to produce the highest ROS activity and to possess the greatest cytotoxicity against MDA-MB-231 breast cancer cells.

Item Type:
Journal Article
Journal or Publication Title:
The Journal of antibiotics
Uncontrolled Keywords:
/dk/atira/pure/subjectarea/asjc/3000/3002
Subjects:
?? drug therapydrug discoverypharmacology ??
ID Code:
214026
Deposited By:
Deposited On:
06 Feb 2024 10:00
Refereed?:
Yes
Published?:
Published
Last Modified:
04 Oct 2024 00:25